Clinical trial

Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

NCT06914102

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Semaglutide Normalized identity: semaglutideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2025-01-14

PhaseN/A

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

HFpEF - Heart Failure With Preserved Ejection Fractionunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

PlaceboDRUG

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06914102 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.